Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance outcomes for women. It is developing novel diagnostic tests for gynecologic disease with focus on ovarian cancer. The company's lead in vitro diagnostic test is Overa, a blood test to aid physicians in pre-surgical assessment of ovarian tumors for malignancy, using an ialgorithmic approach. It serves clinical reference laboratories, hospital laboratories, and physician offices in the United States. Vermillion, Inc. was founded in 1993 and is headquartered in Austin, Texas.

Aspira Women's Health Inc.

Aspira Women's Health Inc. engages in the provision of bio-analytic and diagnostic services. It offers pelvic mass assessment, serum testing, and ovarian mass testing. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

Should you buy, sell, or hold Aspira Women's Health Inc. (AWH) ?

Aspira Women's Health Inc. (AWH) : Buy or Sell